Sanofi
SNY
$47.13
-$0.30-0.63%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 12.70% | 96.90% | -7.22% | -11.54% | |
| Total Other Revenue | 7.15% | -27.99% | 15.74% | 25.23% | |
| Total Revenue | 12.30% | 74.25% | -5.87% | -9.37% | |
| Cost of Revenue | 6.42% | 52.69% | -10.16% | -2.39% | |
| Gross Profit | 14.75% | 86.23% | -3.95% | -12.13% | |
| SG&A Expenses | 10.60% | 126.69% | -16.36% | -18.03% | |
| Depreciation & Amortization | -2.75% | 50.31% | -25.78% | 0.19% | |
| Other Operating Expenses | 38.78% | -40.31% | -8.43% | 17.59% | |
| Total Operating Expenses | 13.87% | 42.02% | -10.85% | -3.46% | |
| Operating Income | 5.69% | 541.65% | 23.29% | -29.90% | |
| Income Before Tax | 15.64% | 184.61% | -23.01% | -55.17% | |
| Income Tax Expenses | -11.52% | 164.82% | 0.02% | -77.06% | |
| Earnings from Continuing Operations | 22.65% | 190.58% | -27.32% | -50.17% | |
| Earnings from Discontinued Operations | 6,439.06% | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -8.47% | -446.51% | 67.96% | 6.00% | |
| Net Income | 276.56% | 208.99% | -23.98% | -42.51% | |
| EBIT | 5.69% | 541.65% | 23.29% | -29.90% | |
| EBITDA | 1.48% | 691.19% | 12.48% | -23.05% | |
| EPS Basic | 286.74% | 208.24% | -23.94% | -42.49% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | 289.65% | 208.24% | -24.23% | -42.49% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -2.59% | 0.15% | -0.10% | -0.04% | |
| Average Diluted Shares Outstanding | -2.93% | -0.22% | 0.26% | -0.04% | |
| Dividend Per Share | -- | 3.23% | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |